Multicenter, Placebo-controlled, Long-term Study of Depigoid Birch 5000 in Adults and Adolescents With Allergic Rhinitis and/or Rhinoconjunctivitis With or Without Intermittent Asthma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
Specific immunotherapy for IgE mediated sensitization to birch pollen. Long-term study to assess safety and efficacy of Depigoid(R)Birch 5000 - a modified pollen extract of Betula alba (Birch) - versus placebo.
Epistemonikos ID: a86de3a1eeb4dadc44d259cfcbb43683840a443e
First added on: May 11, 2024